Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Imaging MS from Shimadzu, Alzheimer's Markers from Proteome Sciences


Shimadzu this week announced the launch of its Imaging Mass Microscrope, iMScope, which combines optical microscopy and mass spectrometry in one instrument.

The device combines an optical microscope and hybrid ion trap time of flight mass spectrometer, allowing for observation of high resolution morphological images via microscopy and for identification and visualization of specific molecules via mass spec.

The device can visualize molecules with sub-cellular resolution, achieving resolution of 5 µm, and allows for analysis of living cells or tissue samples, the company said.

Proteome Sciences this week launched its Alzheimer's CSF 16-plex assay, a protein biomarker panel for simultaneously measuring 16 protein biomarkers in cerebrospinal fluid.

Using selected-reaction monitoring mass spec, the panel is intended for monitoring disease in Alzheimer's patients and could potentially be used as a diagnostic assay, the company said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more